Immatics (IMTX) announced the appointment of Venkat Ramanan, Ph.D., as Chief Financial Officer, effective immediately. Dr. Ramanan joins Immatics from Anthos Therapeutics, a Novartis (NVS) company, where he served as CFO. He will succeed Immatics’ current CFO, Arnd Christ.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMTX: